BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20027480)

  • 1. A bovine herpesvirus 5 recombinant defective in the thymidine kinase (TK) gene and a double mutant lacking TK and the glycoprotein E gene are fully attenuated for rabbits.
    Silva SC; Brum MC; Weiblen R; Flores EF; Chowdhury SI
    Braz J Med Biol Res; 2010 Feb; 43(2):150-9. PubMed ID: 20027480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and growth properties of bovine herpesvirus type 5 recombinants defective in the glycoprotein E or thymidine kinase gene or both.
    Brum MC; Weiblen R; Flores EF; Chowdhury SI
    Braz J Med Biol Res; 2010 Feb; 43(2):217-24. PubMed ID: 19893987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant bovine herpesvirus 5 defective in thymidine kinase and glycoprotein E is immunogenic for calves and confers protection upon homologous challenge and BoHV-1 challenge.
    Anziliero D; Santos CM; Brum MC; Weiblen R; Chowdhury SI; Flores EF
    Vet Microbiol; 2011 Dec; 154(1-2):14-22. PubMed ID: 22019288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and latent infection by bovine herpesvirus type 5 in experimentally infected goats.
    Diel DG; Almeida SR; Brum MC; Dezengrini R; Weiblen R; Flores EF
    Vet Microbiol; 2007 Apr; 121(3-4):257-67. PubMed ID: 17267142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.
    Muylkens B; Meurens F; Schynts F; de Fays K; Pourchet A; Thiry J; Vanderplasschen A; Antoine N; Thiry E
    Vet Microbiol; 2006 Mar; 113(3-4):283-91. PubMed ID: 16321480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity following vaccination with a recombinant multiple-epitope protein of bovine herpesvirus type I in a rabbit model.
    Wen X; Tong X; Wang M; Wang J; Ni H; Ran X
    Appl Microbiol Biotechnol; 2020 Apr; 104(7):3011-3023. PubMed ID: 32002602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone-induced reactivation of bovine herpesvirus type 5 latent infection in experimentally infected rabbits results in a broader distribution of latent viral DNA in the brain.
    Mayer SV; Quadros VL; Vogel FS; Winkelmann ER; Arenhart S; Weiblen R; Flores EF
    Braz J Med Biol Res; 2006 Mar; 39(3):335-43. PubMed ID: 16501813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent infection by bovine herpesvirus type-5 in experimentally infected rabbits: virus reactivation, shedding and recrudescence of neurological disease.
    Caron L; Flores EF; Weiblen R; Scherer CF; Irigoyen LF; Roehe PM; Odeon A; Sur JH
    Vet Microbiol; 2002 Feb; 84(4):285-95. PubMed ID: 11750137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
    Kalthoff D; König P; Trapp S; Beer M
    Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro-generated interspecific recombinants between bovine herpesviruses 1 and 5 show attenuated replication characteristics and establish latency in the natural host.
    Del Medico Zajac MP; Romera SA; Ladelfa MF; Kotsias F; Delgado F; Thiry J; Meurens F; Keil G; Thiry E; Muylkens B
    BMC Vet Res; 2011 May; 7():19. PubMed ID: 21592326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.
    Araujo IL; Dummer LA; Rodrigues PRC; Dos Santos AG; Fischer G; Cunha RC; Leite FPL
    Vaccine; 2018 Nov; 36(50):7708-7714. PubMed ID: 30381153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant bovine IL17A acts as an adjuvant for bovine herpesvirus vaccine.
    Gonçalves VS; Santos FDS; Dos Santos Junior AG; Piraine REA; Rodrigues PRC; Brasil CL; Conrad NL; Leite FPL
    Res Vet Sci; 2021 May; 136():185-191. PubMed ID: 33677208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of bovine herpesvirus type 5 DNA in the central nervous systems of latently, experimentally infected calves.
    Vogel FS; Caron L; Flores EF; Weiblen R; Winkelmann ER; Mayer SV; Bastos RG
    J Clin Microbiol; 2003 Oct; 41(10):4512-20. PubMed ID: 14532175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical protection against caprine herpesvirus 1 genital infection by intranasal administration of a live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine.
    Thiry J; Tempesta M; Camero M; Tarsitano E; Muylkens B; Meurens F; Thiry E; Buonavoglia C
    BMC Vet Res; 2007 Dec; 3():33. PubMed ID: 18053233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle.
    Muylkens B; Meurens F; Schynts F; Farnir F; Pourchet A; Bardiau M; Gogev S; Thiry J; Cuisenaire A; Vanderplasschen A; Thiry E
    J Gen Virol; 2006 Aug; 87(Pt 8):2149-2154. PubMed ID: 16847110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction, characterization and immunogenicity of a glycoprotein E negative bovine herpesvirus-1.1 Egyptian strain "Abu-Hammad".
    El-Kholy AA; Rady DI; Abdou ER; Elseafy MM; Abdelrahman KA; Soliman H
    J Virol Methods; 2013 Dec; 194(1-2):74-81. PubMed ID: 23962750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain.
    Weiss M; Brum MC; Anziliero D; Weiblen R; Flores EF
    Braz J Med Biol Res; 2015 Sep; 48(9):843-51. PubMed ID: 26200229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge.
    Zhang M; Fu S; Deng M; Xie Q; Xu H; Liu Z; Hu C; Chen H; Guo A
    Vaccine; 2011 Nov; 29(48):8943-50. PubMed ID: 21959327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine herpesvirus type 1 marker vaccine induces cross-protection against bubaline herpesvirus type 1 in water buffalo.
    Montagnaro S; De Martinis C; Iovane V; Ciarcia R; Damiano S; Nizza S; De Martino L; Iovane G; Pagnini U
    Prev Vet Med; 2014 Sep; 116(1-2):56-62. PubMed ID: 24985155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.